mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.8 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |